Literature DB >> 33389518

Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.

Lijun Zhao1,2, Honghong Ren1, Rui Zhang1, Tingli Wang1, Yutong Zou1, Huan Xu3, Lin Li3, Mark E Cooper4, Fang Liu5.   

Abstract

PURPOSE: The older population has increased sharply in China. However, renal clinical and histopathological data in this population are lacking. This study investigated the clinicopathologic features and the related risk factors for long-term renal survival in older patients with diabetic nephropathy (DN).
METHODS: In this retrospective observational study, 74 older patients (≥ 60 years old) with type 2 diabetes mellitus and biopsy-proven DN from 2007 to 2019 were included. Clinical data were extracted from electronic records. Renal biopsy specimens were semiquantitatively evaluated using the Renal Pathology Society (RPS) classification system. Cox proportional hazard analysis was used to estimate hazard ratios (HRs) for progression to end-stage renal disease (ESRD).
RESULTS: During the median follow-up period of 22 months, 24 (32%) older patients progressed to ESRD. Older patients who progressed to ESRD had poorer renal function, lower hemoglobin and albumin concentrations, more severe glomerular lesions, and higher percentages of Kimmelstiel-Wilson lesions than those who did not progress to ESRD. After adjusting for age, sex, baseline renal function, and pathological parameters, multivariate Cox proportional hazard analysis showed that RPS glomerular classification (HR 2.49, 95% confidence interval [CI] 1.03-6.04), estimated glomerular filtration rate (eGFR) (HR 0.76, 95% CI 0.58-0.99), and proteinuria (HR 3.85, 95% CI 1.44-10.27) were independent risk factors for progression to ESRD.
CONCLUSION: Lower eGFR, heavier proteinuria, and more severe RPS glomerular lesions were associated with ESRD in older patients with type 2 diabetes mellitus and DN.

Entities:  

Keywords:  Clinicopathologic features; Diabetic nephropathy; End-stage renal disease; Older; Prognostic factor

Year:  2021        PMID: 33389518     DOI: 10.1007/s11255-020-02710-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  27 in total

1.  Renal histology in the elderly: indications and outcomes.

Authors:  Catherine M Brown; Lieneke Scheven; Patrick O'Kelly; Anthony M Dorman; John J Walshe
Journal:  J Nephrol       Date:  2012 Mar-Apr       Impact factor: 3.902

2.  Trends in Chronic Kidney Disease in China.

Authors:  Luxia Zhang; Jianyan Long; Wenshi Jiang; Ying Shi; Xiangxiang He; Zhiye Zhou; Yanwei Li; Roseanne O Yeung; Jinwei Wang; Kunihiro Matsushita; Josef Coresh; Ming-Hui Zhao; Haibo Wang
Journal:  N Engl J Med       Date:  2016-09-01       Impact factor: 91.245

3.  Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors:  Hitoshi Yokoyama; Hitoshi Sugiyama; Hiroshi Sato; Takashi Taguchi; Michio Nagata; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Takao Saito; Yutaka Kiyohara; Shinichi Nishi; Hiroyuki Iida; Kunio Morozumi; Atsushi Fukatsu; Tamaki Sasaki; Kazuhiko Tsuruya; Yukimasa Kohda; Makoto Higuchi; Hideyasu Kiyomoto; Shin Goto; Motoshi Hattori; Hiroshi Hataya; Shoji Kagami; Norishige Yoshikawa; Yuichiro Fukasawa; Yoshihiko Ueda; Hiroshi Kitamura; Akira Shimizu; Kazumasa Oka; Naoki Nakagawa; Takafumi Ito; Shunya Uchida; Kengo Furuichi; Izaya Nakaya; Satoshi Umemura; Keiju Hiromura; Mitsuhiro Yoshimura; Nobuhito Hirawa; Takashi Shigematsu; Masafumi Fukagawa; Makoto Hiramatsu; Yoshio Terada; Osamu Uemura; Tetsuya Kawata; Akira Matsunaga; Aki Kuroki; Yasukiyo Mori; Koji Mitsuiki; Haruyoshi Yoshida
Journal:  Clin Exp Nephrol       Date:  2012-10-11       Impact factor: 2.801

4.  A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases.

Authors:  Fan Yang; Bing Li; Wenpeng Cui; Chunyan He; Shujun Liu; Qiaoyan Guo; Man Wu; Lining Miao; Ping Luo
Journal:  Int Urol Nephrol       Date:  2014-12-25       Impact factor: 2.370

5.  An apocalyptic vision of ageing in China: Old age care for the largest elderly population in the world.

Authors:  Tao Liu; Li Sun
Journal:  Z Gerontol Geriatr       Date:  2014-10-17       Impact factor: 1.281

6.  Renal biopsy in the very elderly.

Authors:  Dimitrios-Anestis Moutzouris; Leal Herlitz; Gerald B Appel; Glen S Markowitz; Bernard Freudenthal; Jai Radhakrishnan; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

7.  The spectrum of biopsy-proven kidney diseases in elderly Chinese patients.

Authors:  Bo Jin; Caihong Zeng; Yongchun Ge; Weibo Le; Honglang Xie; Hao Chen; Shaoshan Liang; Feng Xu; Song Jiang; Zhihong Liu
Journal:  Nephrol Dial Transplant       Date:  2014-07-17       Impact factor: 5.992

8.  Biopsy-proven kidney diseases in the elderly: clinical characteristics, renal histopathological spectrum and prognostic factors.

Authors:  Yue Chen; Ping Li; Chunli Cui; Aihong Yuan; Kun Zhang; Chen Yu
Journal:  J Int Med Res       Date:  2016-09-27       Impact factor: 1.671

9.  The Association Between Physical Activity, Mental Status, and Social and Family Support with Five Major Non-Communicable Chronic Diseases Among Elderly People: A Cross-Sectional Study of a Rural Population in Southern China.

Authors:  Xiang Huang; Huajie Yang; Harry H X Wang; Yongjun Qiu; Xiujuan Lai; Zhiheng Zhou; Fangjian Li; Liwei Zhang; Jiaji Wang; Jimin Lei
Journal:  Int J Environ Res Public Health       Date:  2015-10-21       Impact factor: 3.390

Review 10.  Transforming Growth Factor-Beta1 in Diabetic Kidney Disease.

Authors:  Lijun Zhao; Yutong Zou; Fang Liu
Journal:  Front Cell Dev Biol       Date:  2020-03-24
View more
  1 in total

1.  Auricular Point Acupressure Combined with Compound Lidocaine Cream to Manage Arteriovenous Fistula Puncture Pain: A Multicenter Randomized Controlled Trial.

Authors:  Xiaohui Liu; Wei Wei; Yaqi Wu; Xiao Jiang; Xueqin Liu; Ying Zhang; Chao Hsing Yeh; Yuejuan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-28       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.